CTOs on the Move

LXT

www.lxt.ai

 
LXT is an emerging leader in AI training data to power intelligent technology for global organizations. In partnership with an international network of contributors, LXT collects and annotates data across multiple modalities with the speed, scale and agility required by the enterprise. Our global expertise spans more than 115 countries and over 780 language locales. Founded in 2010, LXT is headquartered in Toronto, Canada with presence in the United States, UK, Egypt, Turkey and Australia. The company serves customers in North America, Europe, Asia Pacific and the Middle East.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.lxt.ai
  • 4312 Village Centre Court
    Mississauga, AB CAN L4Z 1S2
  • Phone: 905.615.1598

Executives

Name Title Contact Details
Amr Nour-Eldin
 Vice President of Technology Profile

Similar Companies

By Light Professional It Services Inc

By Light Professional It Services Inc is a Arlington, VA-based company in the Computers and Electronics sector.

Terrapin Systems

Terrapin Systems is a Rockville, MD-based company in the Computers and Electronics sector.

Web Front Communications

Web Front Communications Inc. is a Toronto, ON-based company in the Computers and Electronics sector.

Jun Group

Jun means truth. Our advertising platform is the honest, efficient way to get millions of people to engage with video and branded content across devices. The world`s best-known brands choose Jun Group because everything we do is brand-safe, visible, and transparent.

Cota

Cota is a technology platform that enables providers, payers, and life science companies involved in diagnosing and treating complex diseases to optimize the care of individual patients and lower the overall cost of the patient population served. It is powered by the patented Cota Nodal Address™ (CNA) system, a unique digital classification methodology built by leading physicians and data scientists. The CNA is the first and only system that precisely categorizes patient factors, their diseases and intended therapies, enabling precision medicine at scale.